Including Diverse Populations

  1. What's It All About?
  2. Who is Responsible?
  3. Resources

The importance of including diverse populations in clinical and translational research is widely accepted and it is critical for better understanding diseases and condition-related in diverse groups of individuals.

Despite multiple national level efforts in the past two decades, individuals from diverse racial and ethnic groups, persons with disabilities, and those aged 65 years or older remain under-represented in clinical and translational research. Additionally, clinical care and translational research among populations across the lifespan, particularly those studies which focus on chronic conditions, are faced with exceptional challenges; including complexity in care, barriers in continuing care (i.e. pediatric to adult care), and secondary health issues resulting from long-term treatment or survivorship of disease.

The Including Diverse Populations (IDP) core supports GHUCCTS vision which emphasizes developing translational research that will have significant impact on populations with health disparities, who have been historically underserved and underrepresented in research. GHUCCTS priority populations include people of diverse racial, ethnic, and cultural backgrounds, people with limited English proficiency (LEP), people with disabilities, older adults, and Veterans.

For more information on the importance of including diverse communities in health research, click on the links below:

Clinical Trials Have Far Too Little Racial and Ethnic Diversity

FDA Encourages More Participation, Diversity in Clinical Trials